Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LENITA HANSON

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1225128572
CMS profile
146171
Location
PORT CHARLOTTE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$2,329.08

109 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,329.08 109

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 109 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LENITA HANSON

NPI 1225128572 · CMS profile ID 146171

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

PORT CHARLOTTE, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 109 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1225128572?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LENITA HANSON, NPI 1225128572, CMS profile ID 146171. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 109 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1225128572?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). LENITA HANSON, NPI 1225128572, CMS profile ID 146171. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 109 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1225128572?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
LENITA HANSON, NPI 1225128572, CMS profile ID 146171, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 109 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1225128572?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

109 matching records · $2,329.08 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 109 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 109.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $14.8506/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829734151 CMS
Insulet Corporation $17.3706/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839824197 CMS
Abbott Laboratories $16.3706/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815543678 CMS
Insulet Corporation $15.3406/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839825269 CMS
AstraZeneca Pharmaceuticals LP $102.3106/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829671064 CMS
CeQur Corporation $11.6506/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855400975 CMS
DEXCOM, INC. $11.6106/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845280137 CMS
Novo Nordisk Inc $25.3706/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811223475 CMS
SANOFI-AVENTIS U.S. LLC $11.9706/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506347 CMS
Lilly USA, LLC $21.5605/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818603731 CMS
Zealand Pharma US, Inc. $28.7205/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800226905 CMS
DEXCOM, INC. $16.8805/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845280135 CMS
Novo Nordisk Inc $21.0705/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811033965 CMS
MannKind Corporation $14.5904/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821058775 CMS
Lilly USA, LLC $12.7004/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818639961 CMS
SANOFI-AVENTIS U.S. LLC $23.4504/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506301 CMS
Lilly USA, LLC $12.3104/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818625755 CMS
Xeris Pharmaceuticals, Inc. $6.9004/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837425325 CMS
Amarin Pharma Inc. $15.8204/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815278507 CMS
Becton, Dickinson and Company $31.4704/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836112273 CMS
CeQur Corporation $12.6804/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855400983 CMS
Esperion Therapeutics, Inc. $125.0004/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838306867 CMS
DEXCOM, INC. $17.8104/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845280133 CMS
Abbott Laboratories $18.0804/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815461013 CMS
Novo Nordisk Inc $19.9304/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811223469 CMS
SANOFI-AVENTIS U.S. LLC $14.2104/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506279 CMS
Zealand Pharma US, Inc. $5.4604/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800226903 CMS
Merck Sharp & Dohme Corporation $14.0703/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848467633 CMS
Zealand Pharma US, Inc. $14.7703/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800226901 CMS
SANOFI-AVENTIS U.S. LLC $15.3403/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506283 CMS
IBSA Pharma Inc. $13.6403/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792507091 CMS
Zealand Pharma US, Inc. $6.6203/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800226899 CMS
SANOFI-AVENTIS U.S. LLC $15.4903/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506271 CMS
Lilly USA, LLC $21.6803/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818583757 CMS
SANOFI-AVENTIS U.S. LLC $13.2603/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506287 CMS
Esperion Therapeutics, Inc. $18.4703/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838306865 CMS
Abbott Laboratories $17.8503/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818427179 CMS
Lilly USA, LLC $14.4803/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818603729 CMS
SANOFI-AVENTIS U.S. LLC $5.4703/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506269 CMS
AstraZeneca Pharmaceuticals LP $16.7202/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829804729 CMS
Lilly USA, LLC $9.1502/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818657081 CMS
Lilly USA, LLC $10.9202/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818625753 CMS
Lilly USA, LLC $15.0502/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818627347 CMS
Merck Sharp & Dohme Corporation $18.8602/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848705525 CMS
SANOFI-AVENTIS U.S. LLC $13.2902/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506289 CMS
Xeris Pharmaceuticals, Inc. $22.9302/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837425321 CMS
Lilly USA, LLC $14.2902/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818595737 CMS
SANOFI-AVENTIS U.S. LLC $22.4001/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843506275 CMS
Zealand Pharma US, Inc. $15.5201/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800226897 CMS
Xeris Pharmaceuticals, Inc. $6.0901/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837425315 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,975.59 87
PY2020 $5,272.28 98
PY2021 $2,329.08 109
PY2022 $2,210.35 71
PY2023 $2,678.25 40
PY2024 $32,950.51 70
PY2025 $26,416.29 30

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $2,499.12 2
PY2025 Principal investigator $35,993.00 10
PY2024 Recipient $2,232.60 2
PY2024 Principal investigator $155,852.73 28
PY2023 Recipient $31,839.85 8
PY2023 Principal investigator $217,611.56 47
PY2022 Recipient $26,323.16 16
PY2022 Principal investigator $178,832.40 104
PY2021 Principal investigator $232,629.35 435
PY2020 Principal investigator $169,198.07 63
PY2019 Principal investigator $175,595.57 83

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $400.00 09/09/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease a No dispute reported 06/30/2026 1225414610
Recipient Bayer Healthcare Pharmaceuticals Inc. $416.52 08/05/2025 Covered Recipient Physician BAY 948862, Clinical characteristics, treatment patterns and outcomes of patients treated with Finerenone in routine clinical practice A prospective non-interventional study. No dispute reported 06/30/2026 1225400908
Recipient Bayer Healthcare Pharmaceuticals Inc. $2,082.60 06/19/2025 Covered Recipient Physician BAY 948862, Clinical characteristics, treatment patterns and outcomes of patients treated with Finerenone in routine clinical practice A prospective non-interventional study. No dispute reported 06/30/2026 1225400910
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $373.00 06/13/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease a No dispute reported 06/30/2026 1225412299
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,696.00 05/29/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease a No dispute reported 06/30/2026 1225412830
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $5,400.00 05/19/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3 study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney disease a No dispute reported 06/30/2026 1225412764
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,621.00 04/28/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225406150
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $7,459.00 03/27/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225402915
Principal investigator 1 Siemens Medical Solutions USA, Inc. $2,850.00 03/25/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
Specimen Collection for Siemens Thyroid Antibody Assays No dispute reported 06/30/2026 1173556700
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $8,323.00 02/20/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225405938
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,621.00 01/28/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225404606
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $4,250.00 01/09/2025 Non-covered Recipient Entity
Hanson Clinical Research Center
BAY 948862, A parallel-group, randomized, prospective, interventional, double-blind, multicenter global Phase 3study to investigate the efficacy and safety of finerenone versus placebo, in addition to standard of care, in participants with chronic kidney No dispute reported 06/30/2026 1225403893